Suppr超能文献

人类转移性乳腺癌中淋巴管生成及肿瘤内淋巴管缺失

Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.

作者信息

Williams Cory S M, Leek Russell D, Robson Alistair M, Banerji Suneale, Prevo Remko, Harris Adrian L, Jackson David G

机构信息

Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK.

出版信息

J Pathol. 2003 Jun;200(2):195-206. doi: 10.1002/path.1343.

Abstract

Early metastasis to lymph nodes is a frequent complication in human breast cancer. However, the extent to which this depends on lymphangiogenesis or on invasion of existing lymph vessels remains controversial. Although proliferating intratumoural lymphatics that promote nodal metastasis have been demonstrated in experimental breast tumours overexpressing VEGF-C, it has yet to be determined whether the same phenomena occur in spontaneous human breast cancers. To address this important issue, the present study investigated the lymphatics in primary human breast carcinoma (75 cases of invasive ductal and lobular breast cancer) by quantitative immunohistochemical staining for the lymphatic endothelial hyaluronan receptor LYVE-1, the blood vascular marker CD34, and the nuclear proliferation marker pKi67. None of the breast carcinomas was found to contain dividing lymph vessels, even in areas of active haemangiogenesis. Furthermore, the majority of non-dividing lymph vessels were confined to the tumour periphery where their incidence was low and unrelated to tumour size, grade or nodal status; rather, their density was inversely correlated with tumour aggressiveness as assessed by macrophage density (p = 0.009), and blood microvessel density (p = 0.05, Spearman Rank), as well as with distance from the tumour edge. Finally, a proportion of the peritumoural lymphatics contained tumour emboli associated with hyaluronan, indicating a possible role for LYVE-1/hyaluronan interactions in lymphatic invasion or metastasis. These results suggest that naturally occurring breast carcinomas invade and destroy lymph vessels rather than promoting their proliferation; that breast tumour lymphangiogenesis may not always occur at physiological VEGF-C levels; and that nodal metastasis can proceed via pre-existing lymphatics.

摘要

早期淋巴结转移是人类乳腺癌常见的并发症。然而,这在多大程度上依赖于淋巴管生成或对现有淋巴管的侵袭仍存在争议。尽管在过表达VEGF-C的实验性乳腺肿瘤中已证实促进淋巴结转移的肿瘤内增殖淋巴管,但在自发性人类乳腺癌中是否发生同样的现象还有待确定。为解决这一重要问题,本研究通过对淋巴管内皮透明质酸受体LYVE-1、血管标志物CD34和核增殖标志物pKi67进行定量免疫组化染色,研究了原发性人类乳腺癌(75例浸润性导管癌和小叶癌)中的淋巴管。即使在活跃的血管生成区域,也未发现乳腺癌含有正在分裂的淋巴管。此外,大多数非分裂的淋巴管局限于肿瘤周边,其发生率较低,与肿瘤大小、分级或淋巴结状态无关;相反,其密度与通过巨噬细胞密度(p = 0.009)和血液微血管密度(p = 0.05,Spearman等级)评估的肿瘤侵袭性呈负相关,也与距肿瘤边缘的距离呈负相关。最后,一部分肿瘤周围淋巴管含有与透明质酸相关的肿瘤栓子,表明LYVE-1/透明质酸相互作用在淋巴侵袭或转移中可能起作用。这些结果表明,自然发生的乳腺癌侵袭并破坏淋巴管而非促进其增殖;乳腺肿瘤淋巴管生成可能并非总是在生理VEGF-C水平发生;并且淋巴结转移可通过预先存在的淋巴管进行。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验